LH:NYE-Laboratory Corporation of America Holdings (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 247.69

Change

+5.16 (+2.13)%

Market Cap

USD 12.76B

Volume

0.67M

Analyst Target

USD 228.47
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Laboratory Corp of America Holdings is a healthcare diagnostics company. The Company along with its subsidiaries provides clinical laboratory services and end-to-end drug development support.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+1.46 (+0.77%)

USD 140.35B
A Agilent Technologies Inc

+2.40 (+2.16%)

USD 32.44B
IQV IQVIA Holdings Inc

+2.24 (+1.61%)

USD 24.71B
DGX Quest Diagnostics Incorporated

+0.62 (+0.36%)

USD 19.12B
QGEN Qiagen NV

+0.62 (+1.40%)

USD 9.05B
CRL Charles River Laboratories

+1.45 (+1.06%)

USD 6.92B
ENZ Enzo Biochem Inc

+0.01 (+0.85%)

USD 0.02B
TMO Thermo Fisher Scientific Inc

+1.62 (+0.40%)

N/A
WAT Waters Corporation

+0.71 (+0.20%)

N/A
MTD Mettler-Toledo International I..

+15.68 (+1.35%)

N/A

ETFs Containing LH

EDOC:LSE Global X Telemedicine & D.. 4.51 % 0.00 %

+0.06 (+0.00%)

USD 4.27M
EDOG:LSE Global X Telemedicine & D.. 4.51 % 0.00 %

+0.03 (+0.00%)

USD 0.30M
CAMX Cambiar Aggressive Value .. 4.37 % 0.00 %

+0.09 (+0.00%)

USD 0.06B
DDOC:F Global X Telemedicine & D.. 4.23 % 0.00 %

+0.09 (+0.00%)

N/A
EDOC:SW Global X Telemedicine & D.. 3.97 % 0.00 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.63 (+0.00%)

N/A
BVNSC 0.00 % 0.00 %

N/A

N/A
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

-0.02 (0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.01% 92% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.01% 92% A 79% B-
Trailing 12 Months  
Capital Gain 26.25% 100% F 89% A-
Dividend Return 0.73% 71% C- 14% F
Total Return 26.98% 92% A 88% B+
Trailing 5 Years  
Capital Gain 64.13% 91% A- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.13% 91% A- 56% F
Average Annual (5 Year Horizon)  
Capital Gain 9.90% 92% A 70% C-
Dividend Return 10.47% 92% A 66% D+
Total Return 0.57% 57% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 38.14% 17% F 22% F
Risk Adjusted Return 27.46% 58% F 46% F
Market Capitalization 12.76B 63% D 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.30 63% 23%
Price/Book Ratio 2.51 75% 34%
Price / Cash Flow Ratio 13.17 63% 31%
Price/Free Cash Flow Ratio 14.93 63% 28%
Management Effectiveness  
Return on Equity 8.98% 63% 56%
Return on Invested Capital 6.40% 63% 51%
Return on Assets 4.18% 38% 68%
Debt to Equity Ratio 66.21% 38% 51%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector